Drug Repurposing for Non-Alcoholic Fatty Liver Disease by Analyzing Networks Among Drugs, Diseases, and Genes
This research demonstrates the potential of drug repurposing to accelerate the development of therapies for NAFLD, offering valuable insights into novel treatment strategies for complex diseases.
Authors
- Md. Altaf-Ul-Amin (ORCID: https://orcid.org/0000-0001-6250-5133)
- Pei Gao (ORCID: https://orcid.org/0000-0003-4410-8075)
- Ahmad Kamal Nasution
- Mahfujul Islam Rumman (ORCID: https://orcid.org/0000-0002-0462-7359)
- Naoaki Ono (ORCID: https://orcid.org/0000-0002-7722-055X)
- Shigehiko Kanaya
Institutions
- Nara Institute of Science and Technology (JP)
Publication Details
- Journal
- Metabolites
- Published
- 2025-04-09
- DOI
- https://doi.org/10.3390/metabo15040255
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00